Product
Budesonide Glycopyrronium Formoterol
1 clinical trial
2 indications
Indication
Pulmonary DiseaseIndication
Chronic obstructive pulmonary diseaseClinical trial
A Real-world, Multicenter, 52-week Prospective Cohort Study to Capture the Reasons for Switch to Triple Combination Therapy and to Assess the Clinical and Patient Reported Outcomes in Adults With Moderate to Severe COPD Treated With Trixeo Aerosphere™ in Routine Care Settings in Greece.Status: Active (not recruiting), Estimated PCD: 2025-05-31